🎉 M&A multiples are live!
Check it out!

Easywell Biomedicals Valuation Multiples

Discover revenue and EBITDA valuation multiples for Easywell Biomedicals and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

Easywell Biomedicals Overview

About Easywell Biomedicals

Easywell Biomedicals Inc is engaged in drug development, manufacturing, and sales of active pharmaceutical ingredients and over-the-counter drug products The company's segment include the Drug development segment and Other segments.


Founded

1998

HQ

Taiwan
Employees

14

Website

easywellbio.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$221M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Easywell Biomedicals Financials

Easywell Biomedicals has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Easywell Biomedicals achieved revenue of $16.3M and an EBITDA of $0.4M.

Easywell Biomedicals expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Easywell Biomedicals valuation multiples based on analyst estimates

Easywell Biomedicals P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $8.2M $16.3M XXX XXX XXX
Gross Profit $2.3M $5.2M XXX XXX XXX
Gross Margin 28% 32% XXX XXX XXX
EBITDA -$2.6M $0.4M XXX XXX XXX
EBITDA Margin -31% 2% XXX XXX XXX
Net Profit -$4.9M -$4.4M XXX XXX XXX
Net Margin -59% -27% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Easywell Biomedicals Stock Performance

As of April 15, 2025, Easywell Biomedicals's stock price is TWD 59 (or $2).

Easywell Biomedicals has current market cap of TWD 7.2B (or $218M), and EV of TWD 7.3B (or $221M).

See Easywell Biomedicals trading valuation data

Easywell Biomedicals Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$221M $218M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Easywell Biomedicals Valuation Multiples

As of April 15, 2025, Easywell Biomedicals has market cap of $218M and EV of $221M.

Easywell Biomedicals's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Easywell Biomedicals's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Easywell Biomedicals and 10K+ public comps

Easywell Biomedicals Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $221M XXX XXX XXX
EV/Revenue 13.6x XXX XXX XXX
EV/EBITDA 575.0x XXX XXX XXX
P/E -74.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -42.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Easywell Biomedicals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Easywell Biomedicals Valuation Multiples

Easywell Biomedicals's NTM/LTM revenue growth is n/a

Easywell Biomedicals's revenue per employee for the last fiscal year averaged $1.2M, while opex per employee averaged $0.8M for the same period.

Over next 12 months, Easywell Biomedicals's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Easywell Biomedicals's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Easywell Biomedicals and other 10K+ public comps

Easywell Biomedicals Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 99% XXX XXX XXX XXX
EBITDA Margin 2% XXX XXX XXX XXX
EBITDA Growth -115% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $1.2M XXX XXX XXX XXX
Opex per Employee $0.8M XXX XXX XXX XXX
S&M Expenses to Revenue 7% XXX XXX XXX XXX
G&A Expenses to Revenue 11% XXX XXX XXX XXX
R&D Expenses to Revenue 51% XXX XXX XXX XXX
Opex to Revenue 68% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Easywell Biomedicals Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Easywell Biomedicals M&A and Investment Activity

Easywell Biomedicals acquired  XXX companies to date.

Last acquisition by Easywell Biomedicals was  XXXXXXXX, XXXXX XXXXX XXXXXX . Easywell Biomedicals acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Easywell Biomedicals

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Easywell Biomedicals

When was Easywell Biomedicals founded? Easywell Biomedicals was founded in 1998.
Where is Easywell Biomedicals headquartered? Easywell Biomedicals is headquartered in Taiwan.
How many employees does Easywell Biomedicals have? As of today, Easywell Biomedicals has 14 employees.
Is Easywell Biomedicals publicy listed? Yes, Easywell Biomedicals is a public company listed on ROCO.
What is the stock symbol of Easywell Biomedicals? Easywell Biomedicals trades under 1799 ticker.
When did Easywell Biomedicals go public? Easywell Biomedicals went public in 2008.
Who are competitors of Easywell Biomedicals? Similar companies to Easywell Biomedicals include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Easywell Biomedicals? Easywell Biomedicals's current market cap is $218M
What is the current revenue growth of Easywell Biomedicals? Easywell Biomedicals revenue growth between 2023 and 2024 was 99%.
Is Easywell Biomedicals profitable? Yes, Easywell Biomedicals is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.